Showing results (1221-1230 of 3,791) with videos related to

Sort By:
Pageof 380
Oncoimmunology|November 20, 2019
Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2Sascha Troschke-Meurer, Nikolai Siebert, Madlen Marx, et al.
Oncoimmunology|November 20, 2019
Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effectsTanja Grimmig, Martin Gasser, Romana Moench, et al.
Oncoimmunology|November 20, 2019
Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitorsKerstin Kapp, Barbara Volz, Detlef Oswald, et al.
Oncoimmunology|November 20, 2019
T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patientsNadia Viborg, Sofie Ramskov, Rikke Sick Andersen, et al.
Oncoimmunology|November 20, 2019
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell compositionJonna Berntsson, Jakob Eberhard, Björn Nodin, et al.
Oncoimmunology|November 20, 2019
Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discoveryRamya Sivakumar, Marina Chan, Jiye Stella Shin, et al.
Oncoimmunology|November 20, 2019
Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancerShuichi Sakamoto, Shunsuke Kagawa, Kazuya Kuwada, et al.
Oncoimmunology|November 20, 2019
Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancerSeyer Safi, Yoshikane Yamauchi, Slava Stamova, et al.
Oncoimmunology|November 20, 2019
Toll-like receptor 3 -926T>A increased the risk of breast cancer through decreased transcriptional activityLei Fan, Peng Zhou, Ao-Xiang Chen, et al.
Oncoimmunology|November 20, 2019
A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibitionJoshua D Bernstock, Nunzio Vicario, Li Rong, et al.
Pageof 380